In order to evaluate the in vivo anti-tumor activity of MSLN-CAR T cells, we established a xenograft ovarian cancer tumor model through intraperitoneal injection of OVCAR3 cells into NCG mice. This evidence concerns the gene MSLN and neoplasm.